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Abstract
Introduction: Malignant melanoma is reported to metastasize to all organs of the human body. Although it is
common for it to metastasize to the gastrointestinal tract, a melanoma located primarily in the gastric mucosa is
an uncommon tumor. Gastrointestinal metastases are rarely diagnosed before death with radiological and
endoscopic techniques.
Case presentation: In this case report the clinical course and treatment of a woman with melanoma of the
stomach, without any other detectable primary lesion, is presented and discussed. A 55-year-old Turkish woman
presented to our clinic with complaints of muscle pain and bone pain in the left side of her chest. During an
upper gastrointestinal system endoscopy, dark cherry-colored, light elevated, round-shaped lesions were taken from
her gastric fundus and from the first part of her duodenum. Biopsies from these samples were determined to be
malignant melanoma by the pathologist.
Conclusion: Metastatic malignant melanoma cases should be examined through endoscopy for gastrointestinal
metastases.
Introduction
Malignant melanoma is reported to metastasize to all
organs of the human body [1-4]. Although it is common
for it to metastasize to the gastrointestinal tract (GIT), a
melanoma located primarily in the gastric mucosa is an
uncommon tumor [5,6]. Gastrointestinal metastases are
rarely diagnosed before death, using radiological and
endoscopic techniques [7-9]. Also, GIT metastases can
appear in various morphological forms, and therefore
immunohistochemistry is often useful in distinguishing
between a malignant melanoma and other malignancies.
The median survival time for melanoma patients present-
ing with gastrointestinal invasion is less than one year [2].
The prolonged survival time reported in a few patients
with gastrointestinal metastases is associated with aggres-
sive surgical treatment, adjuvant chemotherapy and
immunotherapy. The high mortality rate observed in
these patients is associated with multiple metastases to
other organs, such as lungs, liver, pancreas, spleen,
endocrine glands, and brain [6]. In this case report, the
clinical course and treatment of a woman with melanoma
of the stomach, without any other detectable primary
lesion, is presented and discussed.
Case presentation
A 55-year-old Turkish woman presented to our clinic
with complaints of muscle pain and bone pain in the
left side of her chest. She had a diagnosis of malignant
melanoma leading to amputation of her left great toe six
y e a r sa g o .T h i sl e s i o nw a sap r i m a r yf o c u so fm a l i g n a n t
melanoma. She did not have any metastases. One
month prior to this event, our patient felt pain under
her left breast; coronary angiography results were nor-
mal. The patient attended our Physical Therapy clinic,
where no significant abnormalities were found during
the examination. She was then referred to our Gastroen-
terology clinic with a diagnosis of liver abnormality.
Initial tests in our clinic revealed she had a white blood
cell count of 11.1 k/ul, a hematocrit of 31.4, a platelet
count of 437.0 k/uL, positive result for hepatitis B sur-
face antigen, a hepatitis B virus DNA level of 2.17 ×
10
3IU/L, aspartate transaminase levels of 8IU/L, alanine
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levels of 275IU/L, lactate dehydrogenase levels of
1206IU/L and gamma-glutamyltransferase levels of
221IU/L. Blood urea, creatinine, amylase, sodium, potas-
sium, chlorine and calcium ion levels, total bilirubin,
thyroid-stimulating hormone, triiodothyronine, thyroxin,
free triiodothyronine and free thyroxin levels were all
normal. Further tests showed subsequent levels of can-
cer antigen (CA) 125 to be 68.17U/ml (normal range,
1-35U/mL), CA 15-3 to be 23.08U/mL (normal level <
25U/mL), CA 19-9 to be 23.62U/mL (normal level <
40U/mL), ferritin to be 534.8 ng/mL and folate to be
8.67 ng/mL.
Total abdominal-pelvic ultrasonography indicated a
growth in the total size of her liver (craniocaudal dia-
meter 182 mm), with many hypoechoic lesions (metas-
tases), the largest with a diameter of 23 mm at the porta
hepatis, paraaortic, and in the peripancreatic region with
the largest having a diameter 20 mm. These hypoechoic
lesions are perhaps suggestive of metastatic lymphadeno-
pathy. Other intraabdominal organs were normal. Com-
puted tomography (CT) of her thorax showed enlarged
right supraclavicular, upper mediastinal, paratracheal,
subcarinal, right hilar, left axillary and peridiaphragmatic
(largest with a diameter of 35 mm) lymph glands. Several
nodes were observed on both lungs with the largest ones
having diameters of 12 mm on her right lung and 11 mm
on her left lung. Bone structures in the observed region
showed lithic lesions (metastasis). Given that our patient
had a history of malignant melanoma leading to amputa-
tion of her left great toe, upper and lower GIS endoscopy
were administered. During upper GIS endoscopy, dark
cherry-colored, light elevated, round-shaped lesions were
taken from her gastric fundus and from the first part of
her duodenum (Figures 1 and 2). Biopsies from these
samples were determined to be malignant melanoma by
the pathologist (Figure 3). A colonoscopy revealed a
polyp; a biopsy was taken and evaluated to be a tubular
adenoma.
Current findings for our patient were assessed to indi-
cate a malignant melanoma with metastasis to her
stomach, liver, lungs and bones. Stomach metastasis due
to a malignant melanoma is very rare, and such metas-
tases are hardly ever reported among gastric metastases.
This case is the first gastric and duodenal metastases
observed in our clinic due to malignant melanoma. Our
patient was referred to our oncology clinic after the
diagnosis, for chemotherapy.
Discussion
Malignant melanoma is known to metastasize to differ-
ent organs of the human body with an unusual predilec-
tion for the gastrointestinal tract. Gastrointestinal
invasion is a rare condition and is often associated with
the invasion of other visceral organs [6]. Malignant mel-
anoma of the GIT is a rare entity among intestinal neo-
plasms. Primary intestinal melanoma is difficult to
differentiate from metastatic melanoma, especially given
that the primary cutaneous lesion has the potential to
regress and disappear. In addition, melanoma by itself is
a great mimicker of other neoplastic conditions and
m a yc r e a t eam a j o rd i a g n o s t i cc h a l l e n g ew h e np r e s e n t -
ing at an intraabdominal location. The mean survival
time of these patients is consistently less than one year.
The exact clinical incidence of gastrointestinal mela-
n o m ac a n n o tb ed e t e r m i n e df r o ma n yl a r g es e r i e s ,b u t
the stomach, after the small bowel, is the second most
common site involved [6]. Autopsy frequently reveals
gastrointestinal involvement in patients that have died
from melanoma, however little evidence emerges in
antemortem diagnosis and, even then, usually only in
connection with emergency situations such as obstruc-
tions, bleeding or perforation. The frequently asympto-
matic character of gastrointestinal melanoma explains
why it largely eludes detection. Symptoms include
mainly gastrointestinal bleeding, abdominal pain, anor-
exia, nausea and vomiting, weight loss, progressive dys-
plasia, obstruction, and occasionally acute perforation.
Melena in a melanoma patient seems to be a primary
symptom for gastrointestinal metastasis, even in the
absence of other symptoms [10]. In our case our patient
never experienced melena. In the majority of the cases
reported, the gastric involvement was a manifestation of
Figure 1 Endoscopic images of gastric metastasis of the
malignant melanoma.
Figure 2 Endoscopic images of duodenal metastasis of the
malignant melanoma.
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the areas of the human body can be affected by mela-
noma metastases.
Many of the previous reports on the gastric spread
were based on the radiological features of the metas-
tases. Recently, however, endoscopy has been shown to
be a more reliable diagnostic tool [7-9]. It permits exact
morphological evaluation and direct biopsy for patholo-
gical diagnosis. Moreover, by endoscopic follow-up it is
possible to monitor the course of metastases and to
evaluate the results of treatment. The endoscopic classi-
fication of the gastric metastases comprises three main
morphological types. Firstly there are melanotic nodules,
often ulcerated at the tip, which are the most frequently
observed endoscopic feature. Secondly are submucosal
tumor masses, melanotic or not, which are elevated and
ulcerated at the apex. This is the typical aspect of “bull’s
eye” lesions. The third morphological type is mass
lesions, with varying incidence of necrosis and melano-
sis. Additionally, gastric metastases may appear even as
a simple ulcer [6]. Concerning the anatomical site of the
gastric metastases, the majority of them are reported to
occur in the body and the fundus, most often at the
greater curvature with lesserc u r v a t u r el e s i o n sb e i n g
uncommon. In our patient, the endoscopic picture of
the gastric lesion showed it to be melanotic at her gas-
tric fundus and the first part of her duodenum. The
pathological evaluation could confirm the metastatic
nature of the melanoma lesion. GIT metastases can
appear in various morphological forms, and therefore
immunohistochemistry is oftenu s e f u li nd i s t i n g u i s h i n g
between a malignant melanoma and other malignancies
[11,12].
Although surgical treatment has been attempted in
some melanoma patients with gastrointestinal metas-
tases, surgery seems to be of limited practical value and
should be performed only in carefully selected patients
and in patients with complications. The poor general
condition of our patient by the time of the diagnosis,
complicated with other organ (liver, bone and lungs)
metastases, did not allow any surgical treatment [6].
Conclusion
Metastatic melanoma in various areas, from an
unknown primary lesion, is well documented in the lit-
erature [1-12]. The stomach, after the small bowel, is
the second most common site involved. The primary
origin of a melanoma in the stomach is extremely unli-
kely and can be accepted only if the absence of any
other primary lesion is confirmed. Endoscopy has been
shown to be the most reliable form of examination for
A 
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Figure 3 Histopathologic image of gastric metastasis of the
malignant melanoma. Immunohistochemical staining was
performed for S-100 (A), Melan-A (B), H&E (C), and CK (D). Melan-A
(MART-1): A new monoclonal antibody for malignant melanoma
diagnosis.
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invasion is most often associated with the invasion of
other organs and the mean survival time of patients pre-
senting with a gastric metastasis is consistently less than
one year. Therefore, every metastatic malignant mela-
noma case should undergo endoscopic examination for
gastrointestinal metastases.
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